CAS 1294000-61-5

Fórmula: C14H14ClF5N4O2S

InChI: InChI=1S/C14H14ClF5N4O2S/c1-26-6-9-22-24-8(11(14(18,19)20)21-12(24)27-9)5-23-4-7(2-10(23)25)3-13(15,16)17/h7H,2-6H2,1H3/t7-/m1/s1

Chave InChI: DCXFIOLWWRXEQH-SSDOTTSWSA-N

SMILES: COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3C[C@H](CC3=O)CC(F)(F)Cl

Padsevonil

CAS: 1294000-61-5

Pureza: 99%

Ref: IN-DA01EO43

Padsevonil

CAS: 1294000-61-5

Padsevonil

Fórmula: C₁₄H₁₄ClF₅N₄O₂S

Pureza: ≥98%

Peso molecular: 432.8

Ref: 54-BUP21850

Padsevonil

CAS: 1294000-61-5

Padsevonil (UCB-0942) is a potential GABA A receptor orthosteric modulator with antiepileptic activity for the treatment of epilepsy.

Fórmula: C₁₄H₁₄ClF₅N₄O₂S

Pureza: 99.63%

Cor e Forma: Solid

Peso molecular: 432.80

Ref: TM-T16427

Padsevonil

CAS: 1294000-61-5

Fórmula: C₁₄H₁₄ClF₅N₄O₂S

Peso molecular: 432.79

Ref: 4Z-P-259001

Padsevonil

CAS: 1294000-61-5

Padsevonil is an investigational antiseizure medication, which is a synthetic pharmaceutical compound. It is derived from extensive medicinal chemistry research aiming to address complex seizure disorders resistant to conventional treatments. Padsevonil functions by exhibiting a dual mechanism of action. It binds to synaptic vesicle protein 2A (SV2A) with high affinity, similar to levetiracetam but with additional modulation of the benzodiazepine-sensitive gamma-aminobutyric acid-A (GABA-A) receptor. This combined activity potentiates its efficacy in stabilizing neuronal hyperactivity and dampening excitatory neurotransmission, providing a novel angle to tackle refractory seizures.

Fórmula: C₁₄H₁₄ClF₅N₄O₂S

Pureza: Min. 95%

Peso molecular: 432.8 g/mol

Ref: 3D-UBC00061

Padsevonil

CAS: 1294000-61-5

Ref: BE-RMCP008000

Padsevonil

CAS: 1294000-61-5

Fórmula: C₁₄H₁₄ClF₅N₄O₂S

Peso molecular: 432.79

Ref: ST-EA-CP-P410000